About Cytek Biosciences
Cytek Biosciences is a Healthcare company based in Seattle (United States) founded in 1998, and was acquired by EMD Millipore in August 2011. Cytek Biosciences is engaged in developing advanced flow cytometry solutions. It operates on a Direct-to-Consumer (D2C) and Professional Services model. Cytek Biosciences has raised $13.15 million across 5 funding rounds from investors including Orbimed, EMD Millipore and TVM Capital Life Science. Cytek Biosciences offers products and services including Cytek Aurora Evo, Cytek Amnis ImageStream X, and cFluor Reagents. Its focus areas include Biotechnology and Cell Analysis. Its competitors include Fennik Life Sciences and Human Regenerative Technologies.
Company details
Cytek Biosciences is focused on advancing cell analysis through innovative flow cytometry systems. Solutions are provided for research in immuno-oncology, infectious diseases, and inflammatory diseases. The companys full spectrum technology is utilized to enable high-resolution data from multiple fluorochromes. Products and services are offered to support drug discovery, genomics, and immunoprofiling. Operations are conducted in the biotechnology sector with a mission to enhance cancer and cell biology research.
- Total Equity Funding$13.15M (USD)
in 5 rounds
- Latest Funding Round$893.68K (USD), Series C
Jul 2009
- InvestorsOrbimed
& 5 more
- Acquired byEMD Millipore
(Aug 2011)
Products & Services of Cytek Biosciences
Cytek Biosciences offers a comprehensive portfolio of products and services, including Cytek Aurora Evo, Cytek Amnis ImageStream X, and cFluor Reagents.
Advanced flow cytometry system for spectral analysis provided.
Imaging flow cytometry system for detailed cell analysis.
Optimized reagents for full spectrum cytometry panels offered.
Apps and channels of Cytek Biosciences
its YouTube channel Cytek Biosciences has 1.85K subscribers and 30 videos.
Videos from Cytek Biosciences
The most watched videos on Cytek Biosciences's YouTube channel, Cytek Biosciences (1.85K subscribers). Click a video to play it here.
More on Cytek Biosciences.
Funding Insights of Cytek Biosciences
Cytek Biosciences has successfully raised a total of $13.15M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $893.68 thousand completed in July 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.15M
- Total Rounds 5
- Last Round Series C — $893,675
- First Round $1.5M
(Feb 2004)
- Investors Count 5
All 5 funding rounds of Cytek Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2009 | $893,675 | Series C | – | – | – |
| Jan 2008 | $1.01M | Series C | – | – | – |
| Mar 2006 | $11.25M | Series C | – | – | |
| Sep 2004 | $526,907 | Unspecified | – | – | – |
| Feb 2004 | $1.5M | Unspecified | – | – | – |
6 investors in total: 6 institutional.
Investors in Cytek Biosciences
Cytek Biosciences has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Orbimed, EMD Millipore and TVM Capital Life Science.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Capital is invested in life science innovations for healthcare transformation. | tvm-capital.com | Munich, Germany | ||
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Life sciences sector focused VC firm funding companies in the US | medven.com | Emeryville, United States | ||
Capital is provided to support biomedical industry innovations. | 2000 | etpvc.com | South San Francisco, USA | |
| allianceofangels.com | ||||
Chemicals are supplied for industrial and laboratory applications. | 1668 | emdmillipore.com | Burlington, United States |
Investor details for Cytek Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cytek Biosciences
1 people are tracked at Cytek Biosciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
Chris Doman | VP of Global Sales | Leadership |
Complete people profiles for Cytek Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cytek Biosciences
4 dated milestones of Cytek Biosciences across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Cytek Biosciences is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series C, of $894K.
- Exit Acquired by EMD Millipore.
Competitors of Cytek Biosciences
Cytek Biosciences has 2 listed competitors in our database. They include Fennik Life Sciences and Human Regenerative Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| fenniklifesciences.com | 2016 | Kansas, United States | Offers 3D cell culture technologies and services for biomedical research applications. | |||
| humantissue.com | 2016 | El Segundo, United States | Provides advanced tissue allografts for medical applications and wound care. |
Detailed competitors of Cytek Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Cytek Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cytek Biosciences
Complete news archive for Cytek Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytek Biosciences
Cytek Biosciences was founded in 1998 and raised its 1st funding round 6 years after it was founded.
Cytek Biosciences is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Cytek Biosciences is a funded company, having raised a total of $13.15M across 5 funding rounds to date. The company's 1st funding round was a Unspecified of $1.5M, raised on Feb 2004.
Cytek Biosciences is focused on advancing cell analysis through innovative flow cytometry systems. Solutions are provided for research in immuno-oncology, infectious diseases, and inflammatory diseases. The companys full spectrum technology is utilized to enable high-resolution data from multiple fluorochromes. Products and services are offered to support drug discovery, genomics, and immunoprofiling. Operations are conducted in the biotechnology sector with a mission to enhance cancer and cell biology research.
Cytek Biosciences's top competitors include Fennik Life Sciences and Human Regenerative Technologies.
Cytek Biosciences offers Cytek Aurora Evo, Cytek Amnis ImageStream X, and cFluor Reagents.
Cytek Biosciences has 6 investors. Key investors include Orbimed, EMD Millipore, TVM Capital Life Science, MedVenture Associates, and ETP Capital.
Cytek Biosciences operates through Cytek Biosciences.
Yes. Cytek Biosciences was acquired by EMD Millipore in August 2011.